What is Immix Biopharma Inc (IMMX) stock price today?

Immix Biopharma Inc (IMMX) currently trades at $8.93 per share. The stock has a market capitalization of $505.20M and a P/E ratio of —x.

Is IMMX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Immix Biopharma Inc has a Smart Value Score of 20/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

IMMX

Immix Biopharma Inc

NASDAQ: IMMX · HEALTHCARE · BIOTECHNOLOGY

$8.93

+3.48% today

Updated 2026-04-30

Market cap

$505.20M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.89

Dividend yield

—

52W range

$2 – $12

Volume

0.7M

Market cap

$505.20M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.89

Dividend yield

—

52W range

$2 – $12

Volume

0.7M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$17.56

+96.64%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-11.19M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$-89.52M	$0.00	$0.00	$0.00	$0.00
Net income	$-8.23M	$-15.43M	$-21.61M	$-29.44M	$-10.69M
EPS	—	—	—	—	$-0.89
Free cash flow	$-7.41M	$-11.42M	$-15.77M	$-24.66M	$-11.19M
Profit margin	9.19%	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2025-12-10	RACHMAN, ILYA M	Buy	746	$6.67
2025-12-10	MORRIS, GABRIEL S	Buy	770	$6.58
2025-12-08	MORRIS, GABRIEL S	Sale	96,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
IMMX	$505.20M	20	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Immix Biopharma Inc trades at $8.93. Our Smart Value Score of 20/100 indicates the stock is weak.

Frequently asked questions

What is Immix Biopharma Inc's stock price?

Immix Biopharma Inc (IMMX) trades at $8.93.

Is Immix Biopharma Inc overvalued?

Smart Value Score 20/100 (Grade F, Strong Sell).

What is the price target of Immix Biopharma Inc (IMMX)?

The analyst target price is $17.56, representing +96.6% upside from the current price of $8.93.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-55.00%

Beta0.21

50D MA$9.17

200D MA$5.10

Shares out0.05B

Float0.04B

Short ratio—

Avg volume0.7M

Performance

1 week-1.55%

1 month+16.93%

3 months+60.44%

YTD+82.22%

1 year—

3 years—

5 years—

Compare

IMMX vs LLY →IMMX vs JNJ →IMMX vs ABBV →Stock screener →